Navigation Links
Test to detect pre-menstrual syndrome
Date:12/21/2012

This press release is available in German.

Even though there are many women who do not notice any special symptoms, there are some whose pre-menstrual disorders hamper their everyday lives:depressive mood, anxiety, excessive emotional sensitivity, fatigue, lack of concentration, headache, etc. Nevertheless, according to Leire Aperribai, PhD holder in Psychology from the UPV/EHU-University of the Basque Country, unified criteria for defining and diagnosing this disease have yet to be agreed on, "and so it is difficult to develop suitable interventions to treat women suffering from these symptoms."

Aperribai has sought to fill this gap through her PhD thesis. Her first task was to define the disorder, and to do this she took as her basis the 4th version of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association.

This manual defines premenstrual dysphoric disorder and proposes criteria for diagnosing it.For example, it explains that the symptoms are sufficiently serious to cause clear damage, socially as well as in the workplace, and points out that this takes place during the luteal phase, in other words, during the period between ovulation and menstruation.The manual also explains that the symptoms disappear at the onset of menstruation, and for it to be regarded as a disorder, it is necessary to display at least 5 symptoms related to it, and one of them has to be among the following:depressive mood, feelings of desperation or self-rejection; clear internal anxiety, tension, a feeling of not being able to take any more; clear emotional lability, in other words, sadness, bursting into tears or manifestations of emotional over-sensitiveness towards rejection by other people; and irascibility or irritability.

In Aperribai's view, the manual gives a special identity to premenstualdysphoric disorder, despite the fact that it is still classified among those described as "non-specific depressive disorders," so it constitutes a firm proposal as it takes the main groups of symptoms into consideration. Aperribai also added that among the current classifications, this is the one that has been most welcomed.

Reliable and useful

So, taking as the starting point the definitions and criteria provided by the manual, Aperribai has produced a set of questions and has validated them through interviews given by women who are either working or studying on any of the UPV/EHU'sthree campuses.And this way she has verified its reliability.In fact, and in accordance with current calculations, premenstrual dysphoricdisorder is suffered by between 3% and 10% of the population; in the study done by Aperribai, by contrast, it has been found to affect 15%.

The author has explained that this difference is "normal because it concerns test screening.In other words, this is not a diagnostic tool, but a filter to distinguishthose who suffer from the disorder fromthose who do not."In this respect, she has stressed its usefulness, both in the area of research and in health centres.It takes 10 minutes or less to do the test and a lot of progress can be made with it.After that, diagnostic tests are carried out in positive cases and these can take up to two months.

The title of the thesis is "An Evaluation of Premenstrual Dysphoric Disorder: building a screening tool" (UnaevaluacindelTrastornoDisfrico Premenstrual: construccin de unaherramienta de screening).The test is currently being translated into Basque:"We've done one part, but there is still quite a way to go," she says.
'/>"/>

Contact: Aitziber Lasa
a.lasa@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert  

Related medicine news :

1. Charge detector for ion chromatography co-developed by UT Arlington and Thermo Fisher Scientific
2. Targeted micro-bubbles detect artery inflammation, MU study finds
3. Prostate cancer now detectable by imaging-guided biopsy
4. Fruit Flies Use Detection System to Avoid Spoiled Food
5. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
6. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
7. Math detects contamination in water distribution networks
8. New test may improve cervical cancer detection
9. Enhancing breast cancer detection
10. New statistical method offers automatic mitotic cell detection for cancer diagnosis
11. Simple ovarian cancer symptom survey that checks for 6 warning signs may improve early detection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Test to detect pre-menstrual syndrome
(Date:8/18/2017)... St. Louis, Missouri (PRWEB) , ... August 18, 2017 , ... ... ” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To ... way they help children learn social and emotional skills, she created the Time-In Toolkit, ...
(Date:8/18/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has released a ... to the mother of the Savior whom the world calls “Mother Mary”. Yisrayl says when ... role of this historical woman. , “The world bows, kisses the feet of, cries ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... Inc. magazine ... list, the most prestigious ranking of the nation's fastest-growing private companies. This marks the ... exclusive Inc. 5000 ranking . This year’s ranking reflects ASH’s 76 percent overall ...
(Date:8/18/2017)... ... ... “Our Mountains to Climb: A Journey of Love and Faith Through Trials”: ... the faith they shared to overcome struggles in life. “Our Mountains to Climb: A ... J. Corcoran, a retired teacher and happily married since 1999; the author’s personal experiences ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... “Three Narrow ... Roads” is the creation of published author, Rev. Dr. Burnett King Sr., is currently ... coach and founder of the Faith Track Club, Inc., a track-and-field program geared towards ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... CaryRx, a next-generation full-service pharmacy, has announced the ... in the Washington D.C. metropolitan area. ... delivery of medications through the convenience of its patient-friendly mobile ... within one hour to any location in D.C. ... invaluable service to Washington D.C. ," says ...
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
Breaking Medicine Technology: